Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy-Reference-Cited by-同舟云学术

Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy

Published:2018-08-24 Issue:10 Volume:59 Page:4277
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Nicholson Luke¹,Crosby-Nwaobi Roxanne¹,Vasconcelos Joana C.²,Prevost A. Toby²,Ramu Jayashree¹,Riddell Amy³,Bainbridge James W.¹,Hykin Philip G.¹,Sivaprasad Sobha¹

Affiliation:

1. National Institute for Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom

2. Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, United Kingdom

3. King's Clinical Trials Unit at King's Health Partners, King's College London, London, United Kingdom

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-vascular endothelial growth factor injections vs panretinal photocoagulation laser therapy for proliferative diabetic retinopathy – A systematic review and meta-analysis;Ophthalmology Retina;2024-08

2. Retinal vein changes in patients with high-risk proliferative diabetic retinopathy treated with conbercept and panretinal photocoagulation co-therapy: a cohort study;Frontiers in Endocrinology;2023-08-25

3. Determining the Superiority of Vitrectomy vs Aflibercept for Treating Dense Diabetic Vitreous Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Clinical Trials;Clinical Ophthalmology;2023-08

4. Anti‐vascular endothelial growth factor therapy and retinal non‐perfusion in diabetic retinopathy: A meta‐analysis of randomised trials;Acta Ophthalmologica;2023-04-12

5. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy;Cochrane Database of Systematic Reviews;2023-03-20